Effect of Silkworm Pupa Tablets in Gastrointestinal Malignancies at Nutritional Risk Following Radical Surgery

NAActive, not recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 14, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Nutritional DeficiencyGastrointestinal CancerFrailty Syndrome
Interventions
DIETARY_SUPPLEMENT

Silkworm pupa tablets

Participants will begin taking the silkworm pupa tablets immediately upon enrollment, 1200mg/tablet, two tablets a time, twice a day (BID), with a treatment duration of three months.

DIETARY_SUPPLEMENT

Control product

The sham comparator contains 0.5% of the active ingredient of the study product, indistinguishable in appearance. Participants will begin taking the control immediately upon enrollment, 1200mg/tablet, two tablets a time, twice a day (BID), with a treatment duration of three months.

Trial Locations (4)

310000

Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou

310003

The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

310009

The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou

Unknown

Hangzhou Institute of Medicine Chinese Academy of Sciences, Hangzhou

All Listed Sponsors
lead

Xiaosun Liu, MD

OTHER